Vicore webcast: Buloxibutid and the Evolving IPF Landscape

C21 shows promise against COVID-19 where other drugs have failed

Patient insights to shape development of a dCBT for IPF patients

Untangling the dualistic components of the RAS in PF the Yin and Yang

Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics

Report on the ATTRACT study